Insider · CIK 0001430426

IPPOLITO VINCENT P

Reports to the SEC for 2 companies · SCOTTSDALE, AZ

sec.gov

Transactions

Companies

Filings

CIK

0001430426

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-06-24	Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	EVP & Chief Commercial Officer	DDisposition to Issuer	−25.3K sh	—	—	0
2016-06-24	Anacor Pharmaceuticals, Inc.D Disposition to Issuer	EVP & Chief Commercial Officer	DDisposition to Issuer	−69K sh	$99.25	−$6.85M	0
2016-06-24	Anacor Pharmaceuticals, Inc.Performance Restricted Stock UnitsD Disposition to Issuer	EVP & Chief Commercial Officer	DDisposition to Issuer	−6,930 sh	—	—	0
2016-06-24	Anacor Pharmaceuticals, Inc.Performance Restricted Stock UnitsD Disposition to Issuer	EVP & Chief Commercial Officer	DDisposition to Issuer	−5,000 sh	—	—	0
2016-06-24	Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	EVP & Chief Commercial Officer	DDisposition to Issuer	−61K sh	—	—	0
2016-06-24	Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	EVP & Chief Commercial Officer	DDisposition to Issuer	−28.4K sh	—	—	0
2016-03-02	Anacor Pharmaceuticals, Inc.S Sale	EVP & Chief Commercial Officer	SSale	−1,875 sh	$63.56	−$119K	73,510
2016-03-02	Anacor Pharmaceuticals, Inc.S Sale	EVP & Chief Commercial Officer	SSale	−1,829 sh	$64.88	−$119K	67,985
2016-03-02	Anacor Pharmaceuticals, Inc.S Sale	EVP & Chief Commercial Officer	SSale	−3,696 sh	$64.22	−$237K	69,814
2016-03-02	Anacor Pharmaceuticals, Inc.S Sale	EVP & Chief Commercial Officer	SSale	−1,600 sh	$62.23	−$99.6K	75,385
2016-02-03	Anacor Pharmaceuticals, Inc.Performance Restricted Stock UnitsA Award	EVP & Chief Commercial Officer	AAward	+5,000 sh	—	—	5,000
2016-02-03	Anacor Pharmaceuticals, Inc.A Award	EVP & Chief Commercial Officer	AAward	+5,000 sh	—	—	76,985
2016-02-03	Anacor Pharmaceuticals, Inc.Stock Option (right to buy)A Award	EVP & Chief Commercial Officer	AAward	+25.3K sh	—	—	25,299
2016-01-19	Anacor Pharmaceuticals, Inc.S Sale	EVP & Chief Commercial Officer	SSale	−5,300 sh	$96.00	−$509K	71,185
2016-01-19	Anacor Pharmaceuticals, Inc.S Sale	EVP & Chief Commercial Officer	SSale	−13.3K sh	$95.29	−$1.27M	76,485
2016-01-19	Anacor Pharmaceuticals, Inc.S Sale	EVP & Chief Commercial Officer	SSale	−1,200 sh	$93.92	−$113K	89,785
2016-01-19	Anacor Pharmaceuticals, Inc.M Exercise/Conversion	EVP & Chief Commercial Officer	MExercise/Conversion	+20K sh	$19.96	+$399K	90,985
2016-01-19	Anacor Pharmaceuticals, Inc.S Sale	EVP & Chief Commercial Officer	SSale	−200 sh	$96.95	−$19.4K	70,985
2016-01-19	Anacor Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	EVP & Chief Commercial Officer	MExercise/Conversion	−20K sh	—	—	61,000
2016-01-04	Anacor Pharmaceuticals, Inc.S Sale	EVP & Chief Commercial Officer	SSale	−555 sh	$112.21	−$62.3K	71,185
2016-01-04	Anacor Pharmaceuticals, Inc.S Sale	EVP & Chief Commercial Officer	SSale	−200 sh	$113.24	−$22.6K	70,985
2016-01-04	Anacor Pharmaceuticals, Inc.S Sale	EVP & Chief Commercial Officer	SSale	−100 sh	$110.76	−$11.1K	71,740
2015-12-09	Anacor Pharmaceuticals, Inc.S Sale	EVP & Chief Commercial Officer	SSale	−2,730 sh	$108.22	−$295K	71,840
2015-12-09	Anacor Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	EVP & Chief Commercial Officer	MExercise/Conversion	−20K sh	—	—	81,000
2015-12-09	Anacor Pharmaceuticals, Inc.M Exercise/Conversion	EVP & Chief Commercial Officer	MExercise/Conversion	+20K sh	$19.96	+$399K	91,840
2015-12-09	Anacor Pharmaceuticals, Inc.S Sale	EVP & Chief Commercial Officer	SSale	−17.3K sh	$107.85	−$1.86M	74,570
2015-03-03	Anacor Pharmaceuticals, Inc.S Sale	EVP & Chief Commercial Officer	SSale	−1,154 sh	$44.34	−$51.2K	70,603
2015-03-03	Anacor Pharmaceuticals, Inc.S Sale	EVP & Chief Commercial Officer	SSale	−7,846 sh	$43.81	−$344K	71,757
2015-02-03	Anacor Pharmaceuticals, Inc.A Award	EVP & Chief Commercial Officer	AAward	+6,840 sh	—	—	79,603
2015-02-03	Anacor Pharmaceuticals, Inc.Stock Option (right to buy)A Award	EVP & Chief Commercial Officer	AAward	+28.4K sh	—	—	28,400
2015-02-03	Anacor Pharmaceuticals, Inc.Performance Restricted Stock UnitsA Award	EVP & Chief Commercial Officer	AAward	+6,930 sh	—	—	6,930
2012-12-11	MEDICIS PHARMACEUTICAL CORPEmployee Stock OptionD Disposition to Issuer	EVP, Sales & Marketing	DDisposition to Issuer	−36K sh	$5.55	−$200K	0
2012-12-11	MEDICIS PHARMACEUTICAL CORPD Disposition to Issuer	EVP, Sales & Marketing	DDisposition to Issuer	−188K sh	$44.00	−$8.25M	0
2012-04-04	MEDICIS PHARMACEUTICAL CORPF Tax Payment	EVP, Sales & Marketing	FTax Payment	−1,557 sh	$38.23	−$59.5K	187,590
2012-03-07	MEDICIS PHARMACEUTICAL CORPF Tax Payment	EVP, Sales & Marketing	FTax Payment	−607 sh	$34.71	−$21.1K	189,147
2012-03-05	MEDICIS PHARMACEUTICAL CORPF Tax Payment	EVP, Sales & Marketing	FTax Payment	−1,319 sh	$35.01	−$46.2K	189,754
2012-03-01	MEDICIS PHARMACEUTICAL CORPF Tax Payment	EVP, Sales & Marketing	FTax Payment	−1,108 sh	$34.95	−$38.7K	191,073
2012-03-01	MEDICIS PHARMACEUTICAL CORPF Tax Payment	EVP, Sales & Marketing	FTax Payment	−1,530 sh	$34.95	−$53.5K	192,181
2012-02-29	MEDICIS PHARMACEUTICAL CORPA Award	EVP, Sales & Marketing	AAward	+33.1K sh	—	—	193,711
2012-02-27	MEDICIS PHARMACEUTICAL CORPF Tax Payment	EVP, Sales & Marketing	FTax Payment	−5,615 sh	$33.81	−$190K	160,655
2011-05-13	MEDICIS PHARMACEUTICAL CORPEmployee Stock OptionM Exercise/Conversion	EVP, Sales & Marketing	MExercise/Conversion	−45K sh	—	—	0
2011-05-13	MEDICIS PHARMACEUTICAL CORPM Exercise/Conversion	EVP, Sales & Marketing	MExercise/Conversion	+45K sh	$25.10	+$1.13M	225,626
2011-05-13	MEDICIS PHARMACEUTICAL CORPM Exercise/Conversion	EVP, Sales & Marketing	MExercise/Conversion	+40K sh	$29.20	+$1.17M	265,626
2011-05-13	MEDICIS PHARMACEUTICAL CORPM Exercise/Conversion	EVP, Sales & Marketing	MExercise/Conversion	+15K sh	$32.41	+$486K	280,626
2011-05-13	MEDICIS PHARMACEUTICAL CORPS Sale	EVP, Sales & Marketing	SSale	−114K sh	$36.88	−$4.22M	166,270
2011-05-13	MEDICIS PHARMACEUTICAL CORPEmployee Stock OptionM Exercise/Conversion	EVP, Sales & Marketing	MExercise/Conversion	−40K sh	—	—	0
2011-05-13	MEDICIS PHARMACEUTICAL CORPEmployee Stock OptionM Exercise/Conversion	EVP, Sales & Marketing	MExercise/Conversion	−15K sh	—	—	0
2011-04-04	MEDICIS PHARMACEUTICAL CORPF Tax Payment	EVP, Sales & Marketing	FTax Payment	−788 sh	$33.19	−$26.2K	180,626
2011-03-07	MEDICIS PHARMACEUTICAL CORPF Tax Payment	EVP, Sales & Marketing	FTax Payment	−461 sh	$30.76	−$14.2K	181,414
2011-03-05	MEDICIS PHARMACEUTICAL CORPF Tax Payment	EVP, Sales & Marketing	FTax Payment	−805 sh	$31.24	−$25.1K	181,875

Recent filings

Accepted (ET)
Jun 244
Anacor Pharmaceuticals, Inc.0000950103-16-014331
SEC(opens sec.gov)
Mar 44
Anacor Pharmaceuticals, Inc.0001209191-16-106294
SEC(opens sec.gov)
Feb 54
Anacor Pharmaceuticals, Inc.0001209191-16-096109
SEC(opens sec.gov)
Jan 214
Anacor Pharmaceuticals, Inc.0001209191-16-092996
SEC(opens sec.gov)
Jan 54
Anacor Pharmaceuticals, Inc.0001209191-16-089486
SEC(opens sec.gov)

Companies

Address

7720 N. DOBSON RD.

SCOTTSDALE, AZ, 85256